Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 11 Jul 2019 – 20 Aug 2026, limited by Aditya Birla Sun Life Pharma and Healthcare Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Aditya Birla Sun Life Pharma and Healthcare Fund | Nifty 500 |
|---|---|---|
| 11 Jul 2019 | ₹100.00 | ₹100.00 |
| 12 Feb 2020 | ₹115.12 | ₹106.03 |
| 16 Sep 2020 | ₹151.74 | ₹101.75 |
| 20 Apr 2021 | ₹173.93 | ₹127.35 |
| 23 Nov 2021 | ₹185.97 | ₹159.59 |
| 27 Jun 2022 | ₹162.29 | ₹142.02 |
| 30 Jan 2023 | ₹166.87 | ₹156.91 |
| 03 Sep 2023 | ₹203.88 | ₹180.37 |
| 06 Apr 2024 | ₹264.08 | ₹218.83 |
| 09 Nov 2024 | ₹310.25 | ₹239.22 |
| 13 Jun 2025 | ₹301.39 | ₹241.97 |
| 16 Jan 2026 | ₹303.08 | ₹248.09 |
| 20 Aug 2026 | ₹363.68 | ₹248.38 |
| Metric | Aditya Birla Sun Life · Regular NAV ₹36.55 Very High risk ★★★★★ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +15.37% | +5.83% | |
| +20.74% | +15.63% | |
| +13.61% | +13.23% | |
| — | +13.85% | |
| +19.91% | +12.26% | |
| +19.10% | — | |
| +17.82% | +15.60% | |
| +18.20% | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 12.86% | 15.62% | |
| 1.11 | 0.43 | |
| 1.59 | 0.59 | |
| -21.38% | -23.65% | |
| Nifty 500 | — | |
| +10.16% | +3.42% | |
| 0.66 | 0.95 | |
| 107.0% | 105.9% | |
| 56.8% | 93.6% | |
| 2.29% | 2.39% | |
| ₹920.03Cr | ₹1,161Cr | |
| — | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 39% | 45% | |
| Dhaval Shah · 7.2y | — | |
| 11 Jul 2019 | — | |
| 38 | — | |
| 52.1% | — | |
| 2.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.